Service Will Provide Prana™ and Bubbleman Product Lines To Patients In 35 Cities And Municipalities, Eventually Throughout California
DENVER, July 13, 2016 /Weed Wire/ — United Cannabis Corporation (OTCQB: CNAB) (the “Company” or “United Cannabis”) today announced that its partner, the nation’s model cannabis dispensary, Harborside Health Center (“Harborside”), has made delivery of its full-spectrum cannabinoid therapy protocol - Prana Bio Nutrient Medicinals - and its Bubbleman affiliated products available to customers in 35 cities and municipalities in the State of California, including Oakland, Alameda, Berkeley, San Leandro and Emeryville.
United Cannabis, through its subsidiary UCANN California Corporation (“UCANN CA”), and together with Harborside has been distributing its products in California for the past two years. Initially launched as a “boutique” pop up in Harborside’s Oakland dispensary, the companies expanded their partnership this past March, providing Harborside exclusive license and distribution rights throughout California.
Under the terms of the expanded agreement, Harborside will deliver United Cannabis products - including the entire Prana Bio Nutrient Medicinal line and Bubbleman affiliate’s Full Melt Bubble Hash, Dry Sift and Flower Rosin - to patients in more than 35 cities and municipalities. Longer term, Harborside will provide delivery services throughout the State.
Tony Verzura, United Cannabis’ Chief Technology Officer, commented on the partnership, “There is a broad range of patients who can benefit from our products, for whom circumstances make it difficult, if not impossible for them to come to a dispensary. Delivery services are yet another way that Harborside implements its mission to expand and facilitate access to medical cannabis for those in need.”
“Harborside was created to promote wellness by providing patients with a full spectrum of products and services, and delivery is an important part of that mission, enabling us to work with a much larger population than those able to visit one of our facilities,” says Steve DeAngelo, Founder of Harborside.
About United Cannabis Corporation
United Cannabis Corporation was founded to provide leadership in the medical cannabis industry by offering patient driven solutions intent on improving biomedical and pharmaceutical pursuits through the use of cannabis-based research, products and services. The Company has established affiliate relationships with Harborside, Prana Bio Nutrient Medicinals, Bubbleman, Blue River, Cannabinoid Research & Development, DNA Genetics, and Emotek.
The Company’s proprietary A.C.T. Now Program is a robust, holistic program built around United Cannabis’ Prana Bio Medicinals, including nutritional guidelines, nursing support, patient education, on-site visitation and electronic medical chart management. Together, these products and services have had a profound effect on patients diagnosed with many severe illnesses.
For further information, please visit www.unitedcannabis.us.
About Harborside Health Center:
“Harborside Health Center, a nonprofit medical marijuana dispensary with locations in Oakland and San Jose, California, is looked upon as a model of how others could operate.” - The New York Times
Founded in 2006 by Steve DeAngelo, Harborside Health Center is the most respected and largest medical cannabis dispensary in the United States. Harborside has over 200,000 registered patients and was first in the nation to support education for seniors, veterans and families with severely ill children; first in the country to offer CBD-rich medicine; and the first to treat children with Dravet syndrome. Harborside continues to set an example of diversity and compliance, and is one of the prime advocates of diversity, sustainability and economic justice in the industry.
DeAngelo also co-founded the nation’s first cannabis-testing facility, Steep Hill Labs, and the country’s first cannabis investment and research firm, The ArcView Group. His book, The Cannabis Manifesto: A New Paradigm for Wellness, is published by North Atlantic Books and distributed by Penguin/Random House. DeAngelo was named one of the most influential people and “gatekeeper” of the marijuana industry in 2015 by the International Business Times, and one of the most influential people in the cannabis industry in 2014 by the Cannabis Business Executive.
Contact: [email protected]
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.